Sendhilnathan Ramalingam
Duke Medical Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Hematopoietic Stem Cell Transplantation, Lung Cancer Diagnosis and Treatment, Cancer Cells and Metastasis, CAR-T cell therapy research
Most-Cited Works
- Osimertinib or platinum–pemetrexed in EGFR T790M–positive lung cancer(2017)
- → Sox9expression marks a subset of CD24-expressing small intestine epithelial stem cells that form organoids in vitro(2010)152 cited
- → Cartilage-Specific Knockout of the Mechanosensory Ion Channel TRPV4 Decreases Age-Related Osteoarthritis(2016)141 cited
- → Distinct levels of Sox9 expression mark colon epithelial stem cells that form colonoids in culture(2011)80 cited
- → Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study(2020)78 cited
- → Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis(2019)68 cited
- → Survival Comparison in Patients with Stage IV Lung Cancer in Academic versus Community Centers in the United States(2018)37 cited
- → Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients(2020)32 cited
- → Stem Cell Therapy as a Treatment for Autoimmune Disease—Updates in Lupus, Scleroderma, and Multiple Sclerosis(2021)24 cited
- → Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years(2022)17 cited